Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 6:37 PM ET

Biotechnology

Company Overview of Juno Therapeutics Inc.

Executive Profile

Hans E. Bishop

Co-Founder, Chief Executive Officer, President and Director, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
50$7,317,696
As of Fiscal Year 2014

Background

Mr. Hans E. Bishop serves as the Chief Operating Officer of Photothera, a late stage medical device company. Mr. Bishop has more than 18 years of pharmaceutical industry experience. He is Co-founder of Juno Therapeutics Inc. and has been its its Chief Executive Officer since September 2013. He serves as the President of Juno Therapeutics Inc. He served as Consultant of Dendreon Corp. from October 1, 2011 to December 31, 2011. Mr. Bishop served as the Chief Operating ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Director
2012-2015
Former Director, Member of Audit Committee and Member of Corporate Governance Committee
2012-2012
Former Executive Chairman
2013-Present
Co-Founder, Chief Executive Officer, President and Director

Education

BS
Brunel University

Other Affiliations

Annual Compensation

Salary$425,000
Bonus$246,000
Total Annual Compensation$671,000

Stocks Options

Restricted Stock Awards$2,156,250
Exercisable Options$62,594
Unexercisable Options$938,912
Total Number of Options$1,001,506

Total Compensation

Total Annual Cash Compensation$875,000
Total Short Term Compensation$671,000
Other Long Term Compensation$2,156,250
Total Calculated Compensation$7,317,696
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.